Latest News

Every September, Snow celebrates Patient Appreciation Month, dedicated to thanking the patients who share their experiences, perspectives, and time with us. There is no single way to make an impact. From sharing a personal story to supporting a fellow Ambassador or exploring opportunities to get involved, every contribution helps make our community stronger.

It started with a Memorial Garden, created to honor the Ambassadors, and grew from there. Patients are at the heart of what Snow does, and the team wanted to be intentional about sharing that appreciation, to honor the work and the patients behind it. CEO Blake Shewey says, “This annual initiative was chosen deliberately as a moment to ground the whole team and highlight the work and patients we care deeply about.”

While Snow loves bringing the month to life in personal, meaningful ways, the appreciation behind it isn't seasonal. It shows up in how the team recognizes every engagement, and in relationships with patients that outlast the contracts themselves.

Why a relationship, not a transaction

At Snow, engagement is built from the very first conversation with a patient through every phase of the relationship that follows. Patients are brought in early and given real input into how their story gets shaped and shared through a genuine, collaborative process. Their stories and insights show up in live and virtual events, advocacy initiatives, and digital communities that give patients room to connect with each other. It shows up in Advocacy and Recruitment, and in patient support, where Snow's behavioral scientists, learning strategists and content creators, alongside a team of Health Educators, build experiences that are truly real. The throughline is that the patient's needs always come first, and their perspectives stay honest from beginning to end.

Perhaps the strongest measure of a meaningful patient partnership is what happens after a program ends. Many patients, caregivers, and former Patient Ambassadors choose to stay connected, whether through social communities, future opportunities, or conversations with Snow employees. Some have shared their stories in person with team members, creating connections that extend well beyond a single engagement. Those relationships are not built through transactions. They grow from trust, respect, and a shared commitment to keeping the patient perspective at the center.

Why this matters for DTC marketers

According to the Edelman Trust Barometer, pharmaceutical companies remain near the bottom of institutional trust rankings globally, a position they have held for most of the last decade. Every campaign, every patient story, every piece of content is competing against that baseline. That is especially true now, as AI content creates a sea of sameness. People are craving what's real, and authenticity has become the premium brands must pay to earn that trust back.

It takes courage for a patient to share a diagnosis, a treatment journey, or a hard chapter of their life with strangers, knowing it may end up in front of thousands of people. Patients do it because they believe their story might help someone else feel less alone, enable them to ask their doctor a better question, or simply see themselves represented honestly. Snow's Patient Appreciation Month is a chance to pause and elevate the bravery behind every perspective that patients choose to share with us, and the journey that got them there.

Eleven months ago, an FDA warning letter was a rare event. Enforcement letters had fallen from more than 130 a year in the late 1990s to just five in all of 2024. Then came last September, when the FDA's Office of Prescription Drug Promotion (OPDP) sent more than 60 warning and untitled letters in a single day, a number that climbed past 100 within weeks as thousands of additional notices went out to sponsors industry wide.

OPDP has not slowed down since, but this is not just a tightening of compliance. It is about protecting patients and doing right by them as they navigate one of the hardest journeys in their lives. Patients should be able to rely on what they are told about their medications, no matter where they encounter that information. The letters are just the visible part of that effort.

That is why OPDP scrutiny now reaches HCP websites, corporate webpages, influencer content, earned media, and patient testimonials, channels that were barely part of the conversation two years ago but are increasingly where patients form their understanding of a drug's risks and benefits. Enforcement is now extending beyond pharmaceutical brands to telehealth platforms and compounding pharmacies over GLP-1 marketing claims. When a patient or creator's story is part of a paid relationship, OPDP wants that partnership spelled out very clearly.

What this shift means for DTC marketers

In practice, this means the questions DTC marketers should already be asking are the ones OPDP is now asking too. Who is this patient, and how was the story found? Was consent documented before the story was captured, or requested after the fact? Is it clear that the story only reflects one person's experience and experiences may be different for others? When a creator or patient's voice is part of a paid relationship, is that relationship spelled out clearly?

These used to be formalities nobody thought twice about. Now getting them right is critical and could be the difference between a clean review and a warning letter. Beyond that, getting them wrong can cost patient trust, and that shows up in the marketing numbers that matter more than reach. It is the difference between a patient understanding their options well enough to talk to their doctor, and whether they stick with treatment once they start.

How to build patient storytelling that stands up to this new compliance reality

Snow's Patient Ambassador® process has led the industry for 25 years, built on real patient experiences and authentic relationships. It is a proprietary approach that has evolved over the years to meet the latest compliance standards and is customized based on client needs.

For organizations evaluating their own patient storytelling programs, now is the time to ask whether their recruitment, consent, documentation, and review processes would hold up under this new era of compliance review. That's the work Snow does with marketing teams every day, navigating the complexities of this enforcement landscape and using our proprietary process to find the right patients and bring their stories to life.